Comprehensive characterisation of pulmonary and serum surfactant protein D in COPD

BackgroundPulmonary surfactant protein D (SP-D) is considered as a candidate biomarker for the functional integrity of the lung and for disease progression, which can be detected in serum. The origin of SP-D in serum and how serum concentrations are related to pulmonary concentrations under inflammatory conditions is still unclear.MethodsIn a cross-sectional study comprising non-smokers (n = 10), young - (n = 10), elderly smokers (n = 20), and smokers with COPD (n = 20) we simultaneously analysed pulmonary and serum SP-D levels with regard to pulmonary function, exercise, repeatability and its quaternary structure by native gel electrophoresis. Statistical comparisons were conducted by ANOVA and post-hoc testing for multiple comparisons; repeatability was assessed by Bland-Altman analysis.ResultsIn COPD, median (IQR) pulmonary SP-D levels were lower (129(68) ng/ml) compared to smokers (young: 299(190), elderly: 296(158) ng/ml; p < 0.01) and non-smokers (967(708) ng/ml; p < 0.001). The opposite was observed in serum, with higher concentrations in COPD (140(89) ng/ml) as compared to non-smokers (76(47) ng/ml; p < 0.01). SP-D levels were reproducible and correlated with the degree of airway obstruction in all smokers. In addition, smoking lead to disruption of the quaternary structure.ConclusionsPulmonary and serum SP-D levels are stable markers influenced by smoking and related to airflow obstruction and disease state. Smaller subunits of pulmonary SP-D and the rapid increase of serum SP-D levels in COPD due to exercise support the translocation hypothesis and its use as a COPD biomarker.Trial registrationno interventional trial

• Publication year

  2011

• Venue

  Respiratory Research

• Publication date

  2011-03-11

• Fields of study

  Medicine

• Identifiers
  DOI 10.1186/1465-9921-12-29PMID 21396106PMCID 3061904
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Review: Chemical and structural modifications of pulmonary collectins and their functional consequences

  2010cited by this paper
• Integrating lung and plasma expression of pneumo-proteins in developing biomarkers in COPD: a case study of surfactant protein D.

  2010cited by this paper
• Long-term stability and circadian variation in circulating levels of surfactant protein D.

  2010cited by this paper
• Multiplex immune serum biomarker profiling in sarcoidosis and systemic sclerosis

  2009cited by this paper
• Immunologic aspects of chronic obstructive pulmonary disease.

  2009cited by this paper
• Serum surfactant protein D is steroid sensitive and associated with exacerbations of COPD

  2009cited by this paper
• Modification of surfactant protein D by reactive oxygen‐nitrogen intermediates is accompanied by loss of aggregating activity, in vitro and in vivo

  2009cited by this paper
• S-Nitrosylation of Surfactant Protein-D Controls Inflammatory Function

  2008cited by this paper
• Smoking and lung cancer: the role of inflammation.

  2008cited by this paper
• Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.

  2007cited by this paper
• Circulating surfactant protein D as a potential lung-specific biomarker of health outcomes in COPD: a pilot study

  2007cited by this paper
• Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.

  2007cited by this paper
• Surfactant protein levels in bronchoalveolar lavage after segmental allergen challenge in patients with asthma

  2006cited by this paper
• Patterns of inflammation and the use of reversibility testing in smokers with airway complaints

  2006cited by this paper
• Expression of Xenobiotic Metabolizing Enzymes in Different Lung Compartments of Smokers and Nonsmokers

  2006cited by this paper
• Surfactant proteins SP-A and SP-D: structure, function and receptors.

  2006cited by this paper
• Oxidative damage to surfactant protein D in pulmonary diseases

  2006cited by this paper
• Immunoregulatory functions of surfactant proteins

  2005cited by this paper
• A Common Polymorphism in the SFTPD Gene Influences Assembly, Function, and Concentration of Surfactant Protein D1

  2005cited by this paper
• Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease.

  2005cited by this paper
• Serum surfactant protein D is elevated in allergic patients

  2004cited by this paper
• Neutrophil Serine Proteinases Inactivate Surfactant Protein D by Cleaving within a Conserved Subregion of the Carbohydrate Recognition Domain*

  2004cited by this paper
• Enhanced Lung Injury and Delayed Clearance of Pneumocystis carinii in Surfactant Protein A-Deficient Mice: Attenuation of Cytokine Responses and Reactive Oxygen-Nitrogen Species

  2004cited by this paper
• By binding SIRPalpha or calreticulin/CD91, lung collectins act as dual function surveillance molecules to suppress or enhance inflammation.

  2003cited by this paper
• Comparative study of KL-6, surfactant protein-A, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases.

  2002cited by this paper
• The intrauterine expression of surfactant protein D in the terminal airways of human fetuses compared with surfactant protein A

  2002cited by this paper
• Pulmonary-specific expression of SP-D corrects pulmonary lipid accumulation in SP-D gene-targeted mice.

  2000cited by this paper
• Localization of Lung Surfactant Protein D on Mucosal Surfaces in Human Tissues1

  2000cited by this paper
• Lung epithelium-specific proteins: characteristics and potential applications as markers.

  1999cited by this paper
• Biosynthesis of Surfactant Protein D

  1996cited by this paper
• Pulmonary surfactant protein D in sera and bronchoalveolar lavage fluids.

  1995cited by this paper
• Molecular structure of pulmonary surfactant protein D (SP-D).

  1994cited by this paper
• Blue native electrophoresis for isolation of membrane protein complexes in enzymatically active form.

  1991cited by this paper
• Protein damage and degradation by oxygen radicals. II. Modification of amino acids.

  1987cited by this paper
• levels: a cross-sectional study.

  year unknowncited by this paper

• Surfactant protein D expression and clinical value of hypobaric hypoxia-induced acute lung injury and acute respiratory distress syndrome patients

  2025cites this paper
• Promoting immune defensive responses of epithelial cells in airway disease

  2025cites this paper
• Immature Surfactant Protein Type B and Surfactant Protein Type D Correlate with Coronary Heart Disease in Patients with Type 2 Diabetes

  2024cites this paper
• Surfactant protein D prevents mucin overproduction in airway goblet cells via SIRPα

  2024cites this paper
• "Update prognostic potency of surfactant protein D (SP-D) in the COVID-19 landscape: an In-depth meta-analytical exploration".

  2024cites this paper
• Pulmonary Surfactant: A Mighty Thin Film.

  2023cites this paper
• Molecular Impact of Conventional and Electronic Cigarettes on Pulmonary Surfactant

  2023cites this paper
• Bioaerosol-induced in vitro activation of toll-like receptors and inflammatory biomarker expression in waste workers

  2023cites this paper
• Lung injury and oxidative stress induced by inhaled chlorine in mice is associated with proinflammatory activation of macrophages and altered bioenergetics.

  2023cites this paper
• The acute effects of endurance exercise on epithelial integrity of the airways in athletes and non-athletes: A systematic review and meta-analysis.

  2023cites this paper
• Study of Serum Surfactant Protein D Levels in Chronic Obstructive Pulmonary Disease Patients

  2023cites this paper
• Different expression of circulating microRNA profile and plasma SP-D in Tibetan COPD patients

  2022cites this paper
• Aging-associated and CD4 T-cell–dependent ectopic CXCL13 activation predisposes to anti–PD-1 therapy-induced adverse events

  2022cites this paper
• Multiomics links global surfactant dysregulation with airflow obstruction and emphysema in COPD

  2022cites this paper
• Complex Evaluation of Surfactant Protein A and D as Biomarkers for the Severity of COPD

  2022cites this paper
• Blood Levels of Indicators of Lower Respiratory Tract Damage in Chronic Bronchitis in Patients with Abdominal Obesity

  2022cites this paper
• Commentary: Pattern Recognition Proteins: First Line of Defense Against Coronaviruses

  2022cites this paper
• Association of serum surfactant protein D and SFTPD gene variants with asthma in Danish children, adolescents, and young adults

  2021cites this paper
• Expression of Surfactant protein D (SP-D) distinguishes severe pandemic influenza A(H1N1) from COVID-19

  2021cites this paper
• Review of recent lung biomarkers of potential harm/effect for tobacco research

  2021cites this paper
• Revisiting the role of pulmonary surfactant in chronic inflammatory lung diseases and environmental exposure

  2021cites this paper
• Tanimilast, A Novel Inhaled Pde4 Inhibitor for the Treatment of Asthma and Chronic Obstructive Pulmonary Disease

  2021cites this paper
• Developmental endothelial locus-1 as a potential biomarker for the incidence of acute exacerbation in patients with chronic obstructive pulmonary disease

  2021cites this paper
• The Role of Surface in the Pathogenesis and Treatment of COVID-19

  2021cites this paper
• Surfactant protein D concentration in a pediatric population with suspected sleep disorder

  2021cites this paper
• The interaction effect of aerobic exercise and vitamin D supplementation on inflammatory factors, anti-inflammatory proteins, and lung function in male smokers: a randomized controlled trial

  2021influential citation
• Full-Length Recombinant hSP-D Binds and Inhibits SARS-CoV-2

  2021cites this paper
• Abdominal obesity and the level of markers of lower respiratory tract damage in patients with chronic bronchitis

  2021cites this paper
• Classes of drugs that target the cellular components of inflammation under clinical development for COPD

  2021cites this paper
• Surfactant protein D: a predictor for severity of community-acquired pneumonia in children

  2021cites this paper
• Increased serum SP-D in identification of high-risk smokers at high risk of COPD.

  2021cites this paper
• Neutrophils and IL-1α Regulate Surfactant Homeostasis during Cigarette Smoking

  2021cites this paper
• Expression of Surfactant Protein D Distinguishes Severe Pandemic Influenza A(H1N1) from Coronavirus Disease 2019

  2021cites this paper
• Surfactant protein D concentrations in serum and bronchoalveolar lavage fluid from young healthy horses on pasture and in a barn environment.

  2021cites this paper
• Air particulate matter pollution and circulating surfactant protein: A systemic review and meta-analysis.

  2021cites this paper
• SP-A and SP-D: Dual Functioning Immune Molecules With Antiviral and Immunomodulatory Properties

  2021influential citation
• The effect of physical preparedness levels on serum levels of CC16, SP-D and lung function in endurance runners

  2020cites this paper
• Intra-individual variation of particles in exhaled air and of the contents of Surfactant protein A and albumin

  2020cites this paper
• The effect of aerobic exercise and vitamin D supplementation on in ammatory factors, anti- in ammatory proteins, and lung function in male smokers: A randomized controlled trial

  2020influential citation
• CORESTA Biomarkers Sub-Group Technical Report Review of Recent Lung Biomarkers of Potential Harm / Effect for Tobacco Research September 2020

  2020influential citation
• Effects of smoking on the level of sp-a and sp-d surfactant proteins in the blood of patients without bronchopulmonary diseases

  2020cites this paper
• Влияние курения на уровни сурфактантных белков SP-A и SP-D в крови у пациентов без бронхолегочных заболеваний

  2020cites this paper
• Respiratory effects induced by occupational exposure to refractory ceramic fibers

  2020cites this paper
• Acrolein in cigarette smoke attenuates the innate immune responses mediated by surfactant protein D.

  2020cites this paper
• SP-A and SPD : dual functioning immune molecules with antiviral and 1 immunomodulatory properties 2

  2020influential citation
• Inhalation of titanium dioxide (P25) nanoparticles to rats and changes in surfactant protein (SP-D) levels in bronchoalveolar lavage fluid and serum

  2019cites this paper
• Molecular Characteristics and Treatment of Endothelial Dysfunction in Patients with COPD: A Review Article

  2019cites this paper
• تأثیر یک جلسه شنای استقامتی بر غلظت پروتئین سلول کلارا و CRP در مردان شناگر استقامتی نخبه و تفریحی

  2019cites this paper
• تأثیر یک جلسه شنای استقامتی بر غلظت پروتئین سلول کلارا و CRP در مردان شناگر استقامتی نخبه و تفریحی

  2019cites this paper
• Pulmonary Health and Disorders

  2019cites this paper
• Plasma surfactant Protein-D levels in healthy subjects and COPD patients.

  2019cites this paper
• Simvastatin Therapy and Bronchoalveolar Lavage Fluid Biomarkers in Chronic Obstructive Pulmonary Disease.

  2019cites this paper
• Surfactant protein D as a marker for pulmonary complications in pediatric patients with sickle cell disease: Relation to lung function tests

  2019cites this paper
• The Effect of Endurance Swimming Activity on the Serum Concentration of Surfactant D and Clara Cell Proteins in Elite Swimmers: A Clinical Trial

  2019cites this paper
• Chemokines in COPD: From Implication to Therapeutic Use

  2019cites this paper
• Pulmonary hypertension and chronic lung disease: where are we headed?

  2019cites this paper
• Blood and sputum protein biomarkers for chronic obstructive pulmonary disease (COPD)

  2018cites this paper
• Surfactant Protein D in Respiratory and Non-Respiratory Diseases

  2018influential citation
• Pulmonary surfactant-associated proteins and inflammatory factors in obstructive sleep apnea

  2018cites this paper
• Irritant-induced asthma to hypochlorite in mice due to impairment of the airway barrier

  2018cites this paper
• Circulating Surfactant Protein-D Is Associated With Clinical Outcomes in Peripheral Artery Disease Patients Following Endovascular Therapy.

  2018cites this paper
• Surfactant Proteins A and D: Trimerized Innate Immunity Proteins with an Affinity for Viral Fusion Proteins

  2018cites this paper
• Surfactant Protein D Deficiency Aggravates Cigarette Smoke-Induced Lung Inflammation by Upregulation of Ceramide Synthesis

  2018cites this paper
• Surfactant protein D multimerization and gene polymorphism in COPD and asthma

  2018cites this paper
• Study of Role of Surfactant Protein-D, Malondialdehyde, Protein Carbonyland its Correlation with Airflow Obstruction (FEV1% Predicted) inPatients with Smoker Chronic Obstructive Pulmonary Disease (COPD)

  2017cites this paper
• Serum Surfactant Protein D as a Biomarker for Measuring Lung Involvement in Obese Patients With Type 2 Diabetes

  2017cites this paper
• Association of multiple genetic variants with chronic obstructive pulmonary disease susceptibility in Hainan region

  2017cites this paper
• Surfactant protein D is a causal risk factor for COPD: results of Mendelian randomisation

  2017cites this paper
• Diving and pulmonary physiology: Surfactant binding protein, lung fluid and cardiopulmonary test changes in professional divers.

  2017cites this paper
• The value of blood cytokines and chemokines in assessing COPD

  2017cites this paper
• Surfactant Protein-D: A sensitive predictor for efficiency of preoperative pulmonary rehabilitation.

  2017cites this paper
• Correlation analysis of surfactant protein A and surfactant protein D with lung function in exhaled breath condensate from lung cancer patients with and without COPD.

  2017cites this paper
• Surfactant Proteins in Smoking-Related Lung Disease.

  2016cites this paper
• Correlations of SPD genetic polymorphisms and protein expression with the pathogenesis and severity of respiratory distress syndrome in preterm infants

  2016cites this paper
• The role of serum surfactant protein D as a biomarker of exacerbation of chronic obstructive pulmonary disease

  2016cites this paper
• Influence of Smoking in Interstitial Pneumonia Presenting with a Non-Specific Interstitial Pneumonia Pattern

  2016influential citation
• Pulmonary Administration of GW0742, a High-Affinity Peroxisome Proliferator-Activated Receptor Agonist, Repairs Collapsed Alveoli in an Elastase-Induced Mouse Model of Emphysema.

  2016cites this paper
• Effects of Bufei Yishen Granules Combined with Acupoint Sticking Therapy on Pulmonary Surfactant Proteins in Chronic Obstructive Pulmonary Disease Rats

  2016cites this paper
• Increased CD11b and Hypoxia-Inducible Factors-1alpha Expressions in the Lung Tissue and Surfactant Protein-D Levels in Serum Are Related with Acute Lung Injury in Severe Malaria of C57BL/6 Mice

  2016cites this paper
• Potential inflammatory markers in obstructive sleep apnea-hypopnea syndrome.

  2016cites this paper
• Surfactant protein D, a clinical biomarker for chronic obstructive pulmonary disease with excellent discriminant values

  2016influential citation
• Surfactant protein B: From biochemistry to its potential role as diagnostic and prognostic marker in heart failure.

  2016cites this paper
• Prognostic significance of surfactant protein A, surfactant protein D, Clara cell protein 16, S100 protein, trefoil factor 3, and prostatic secretory protein 94 in idiopathic pulmonary fibrosis, sarcoidosis, and chronic pulmonary obstructive disease.

  2016cites this paper
• [Multicenter clinical efficacy observation of integrated Traditional Chinese Medicine-Western Medicine treatment in acute onset period of pulmonary heart disease].

  2016cites this paper
• Surfactant protein D is a useful biomarker for monitoring acute lung injury in rats

  2016cites this paper
• Airway Surfactant Protein D Deficiency in Adults With Severe Asthma.

  2016cites this paper
• Biological Markers For Chronic Obstructive Pulmonary Disease And Asthma

  2016influential citation
• Multicenter clinical efficacy observation of integrated Traditional Chinese Medicine-Western Medicine treatment in acute onset period of pulmonary heart disease

  2016cites this paper
• Plasma pro-surfactant protein B and lung function decline in smokers

  2015cites this paper
• Pulmonary surfactant in the airway physiology: a direct relaxing effect on the smooth muscle.

  2015cites this paper
• Influencia genética de las proteínas surfactantes SP-A y SP-D en la neumonía, la gripe por A (H1N1) 2009 y el asma alérgico

  2015cites this paper
• Reproducibility of biomarkers in induced sputum and in serum from chronic smokers.

  2015cites this paper
• Genetic variants of pulmonary SP‐D predict disease outcome of COPD in a Chinese population

  2015cites this paper
• Effects of Cigarette Smoke, Cessation, and Switching to Two Heat-Not-Burn Tobacco Products on Lung Lipid Metabolism in C57BL/6 and Apoe−/− Mice—An Integrative Systems Toxicology Analysis

  2015cites this paper
• Challenges and Current Efforts in the Development of Biomarkers for Chronic Inflammatory and Remodeling Conditions of the Lungs

  2015cites this paper
• C1q Deficiency Promotes Pulmonary Vascular Inflammation and Enhances the Susceptibility of the Lung Endothelium to Injury*

  2015cites this paper
• Comprehensive analysis of gene-expression profile in chronic obstructive pulmonary disease

  2015cites this paper
• Fucosylated surfactant protein-D is a biomarker candidate for the development of chronic obstructive pulmonary disease.

  2015cites this paper
• Surfactant protein D, Club cell protein 16, Pulmonary and activation-regulated chemokine, C-reactive protein, and Fibrinogen biomarker variation in chronic obstructive lung disease

  2014influential citation
• Increased serum levels of lipocalin-1 and -2 in patients with stable chronic obstructive pulmonary disease

  2014cites this paper